Trials / Completed
CompletedNCT02259309
Immune Modulation by Misoprostol
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The present study is designed to address the null hypothesis that there is no difference in the local and systemic immunomodulatory effects of buccally or vaginally administered misoprostol in healthy, reproductive-age women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol - buccal | buccal administration |
| DRUG | Misoprostol - vaginal | vaginal administration |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-07-01
- Completion
- 2015-11-01
- First posted
- 2014-10-08
- Last updated
- 2016-01-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02259309. Inclusion in this directory is not an endorsement.